MENACTRA: payments to doctors
Payments that named MENACTRA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $218K
- Providers
- 9,083
- Transactions
- 12,479
- Average per transaction
- $17
The per-transaction average — $17 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 9,083 providers the average total is $24, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sanofi Pasteur Inc. | $217,885 | 100.0% |
| Sanofi-aventis U.S. LLC | $30 | 0.0% |
| Vaxserve Inc. | $14 | 0.0% |